Lilly to Acquire Kelonia in $7 Billion Gene Therapy Deal
Eli Lilly and Company and Kelonia Therapeutics, Inc. ("Kelonia"), a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced a definitive agreement for…
Read More...
Read More...
